PHARMACY

Trump, House Democrats reach deal on USMCA trade agreement

House Democrats have secured multiple policy changes in the USMCA, including those related to prescription drug pricing,

2019 Pharmacy Innovator of the Year: Publix's relationship-based pharmacy

Read about DSN’s 2019 Pharmacy Innovator of the Year, Publix, and how its team focuses on relationships with patients, payers and partners to build an exceptional pharmacy operation.

What’s in a name: Private-label demand continues to grow

Based on the level of innovation in private-label health, beauty care and general merchandise, it is clear that retailers and suppliers are looking to surpass customer expectations.

OptumRx acquires Diplomat Pharmacy

Diplomat and OptumRx's combination will expand the innovative specialty pharmacy and infusion solutions that OptumRx can offer.

Par launches generic Afinitor

Afinitor 2.5 mg, 5 mg and 7 mg tablets had a market value of roughly $412 million over the last four quarters, according to IQVIA.

Fresenius Kabi debuts generic Invanz

Fresenius Kabi's generic Invanz is available in a 1-g vial.

Staying centered: Publix builds out its central-fill facility to enable patient care

Before 2013, Publix’s central-fill pharmacy decidedly was low tech.

Compounding pharmacies work to navigate handling updates

Compounding pharmacies currently are gearing up for a change in USP’s Chapter <800> Hazardous Drugs—Handling in Healthcare Settings.

Amgen gets FDA nod for biosimilar Remicade

Amgen's biosimilar Avsola offers a biological treatment option to patients across critical disease states, including chronic inflammatory conditions.

NACDS announces speakers for its 2020 Annual Meeting

The NACDS 2020 Annual Meeting will feature Pulitzer Prize-winning author Jon Meacham and General James Mattis.

Automation, tech companies rethink pharmacy pain points

Pharmacy technology and automation companies are stepping up to the plate to ensure that pharmacists can juggle their roles successfully.

Pharmacy groups applaud bipartisan drug pricing package

Pharmacy groups applaud the Grassley-Wyden bill, that would address DIR fees, and lower patient costs.

Amneal gets FDA green light for first generic NuvaRing

NuvaRing had a market value of roughly $976 million for the 12 months ended Oct. 31, 2019, according to IQVIA.

NACDS Foundation Dinner raises nearly $1.9M for public health, patient care initiatives

The NACDS Foundation Dinner raised funds for health initiatives, and also honored two heroes for work in preventing and treating opioid abuse.